Babaran, Geraldine .

HRN: 27-10-43  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2025
CEFUROXIME 1.5GM (VIAL)
05/12/2025
05/12/2025
IV
1.5
PTOR
Previous Uterine Scar, Malpresentation
Waiting Final Action 
05/12/2025
CEFUROXIME 500MG (TAB)
05/13/2025
05/19/2025
ORAL
500mg
2 Times A Day
S/P LTCS
Waiting Final Action 
05/12/2025
CEFUROXIME 1.5GM (VIAL)
05/12/2025
05/13/2025
IV
1500mg
Every 8 Hours
S/P LTCS
Waiting Final Action 
05/14/2025
MUPIROCIN 2%, 15G (TUBE)
05/14/2025
05/20/2025
TOPICAL
Pea Size
Od
Post Cs
Waiting Final Action 
05/16/2025
AZITHROMYCIN 500MG TABLET (TAB)
05/16/2025
05/22/2025
PO
500mg
OD
Cap Mr
Rejected 
05/16/2025
AZITHROMYCIN 500MG TABLET (TAB)
05/16/2025
05/20/2025
PO
500mg
Bid
Cap Mr
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: